Quantitative analysis of the transrenal excretion of circulating EBV DNA in nasopharyngeal carcinoma patients

Clinical Cancer Research

Volumn 14, Issue 15, 2008, Pages 4809-

  Chan, K C Allen ^a   Leung, Sing F ^a   Yeung, Sze W ^a   Chan, Anthony T C ^a   Lo, Y M Dennis ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; VIRUS DNA;

ADULT; AMPLICON; ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FEMALE; HUMAN; HYDRATION; KIDNEY CONCENTRATING CAPACITY; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; PLASMA CLEARANCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; URINARY EXCRETION; BLOOD; CARCINOMA; CASE CONTROL STUDY; DISEASE FREE SURVIVAL; METABOLISM; MIDDLE AGED; NASOPHARYNX TUMOR; PROGNOSIS; URINE; VIROLOGY; VIRUS INFECTION;

ADULT; CARCINOMA; CASE-CONTROL STUDIES; CREATININE; DISEASE-FREE SURVIVAL; DNA, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 51049091006     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-08-1112     Document Type: Article

References (21)

1. Chan KCA, Lo YMD. Circulating tumour-derived nucleic acids in cancer patients: potential applications as tumour markers. Br J Cancer 2007;96:681-5.
2. To EW, Chan KCA, Leung SF, et al. Rapid clearance of plasma Epstein-Barr virus DNA after surgical treatment of nasopharyngeal carcinoma. Clin Cancer Res 2003;9:3254-9.
3. Lo YMD, Leung SF, Chan LYS, et al. Kinetics of plasma Epstein-Barr virus DNA during radiation therapy for nasopharyngeal carcinoma. Cancer Res 2000;60: 2351-5.
4. Botezatu I, Serdyuk 0, Potapova G, et al. Genetic analysis of DNA excreted in urine: a new approach for detecting specific genomic DNA sequences from cells dying in an organism. Clin Chem 2000;46:1078-84.
5. Li Y, Zhong XY, Kang A, Troeger C, Holzgreve W, Hahn S. Inability to detect cell free fetal DNA in the urine of normal pregnant women nor in those affected by preeclampsia associated HELLP syndrome. J Soc Gynecol Investig 2003;10:503-8.
6. Majer S, Bauer M, Magnet E, et al. Maternal urine for prenatal diagnosis-an analysis of cell-free fetal DNA in maternal urine and plasma in the third trimester. Prenat Diagn 2007;27:1219-23.
7. Illanes S, Denbow ML, Smith RP, Overton TG, Soothill PW, Finning K. Detection of cell-free fetal DNA in maternal urine. Prenat Diagn 2006;26:1216-8.
8. Hoque MO, Begum S, Topaloglu O, et al. Quantitative detection of promoter hypermethylation of multiple genes in the tumor, urine, and serum DNA of patients with renal cancer. Cancer Res 2004;64:5511-7.
9. Yu J, Zhu T, Wang Z, et al. A novel set of DNA methylation markers in urine sediments for sensitive/specific detection of bladder cancer. Clin Cancer Res 2007;13: 7296-304.
10. Su YH, Wang M, Aiamkitsumrit B, Brenner DE, Block TM. Detection of a K-ras mutation in urine of patients with colorectal cancer. Cancer Biomark 2005;1:177-82.
11. Lo YMD, Tein MS, Lau TK, et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet1998;62:768-75.
12. Lo YMD, Wong IH, Zhang J, Tein MS, Ng MH, Hjelm NM. Quantitative analysis of aberrant p16 methylation using real-time quantitative methylationspecific polymerase chain reaction. Cancer Res 1999; 59:3899-903.
13. Chan KCA, Chan ATC, Leung SF, et al. Investigation into the origin and tumoral mass correlation of plasma Epstein-Barr virus DNA in nasopharyngeal carcinoma. Clin Chem 2005;51:2192-5.
14. Lo YMD. Molecular testing of urine: catching DNA on the way out. Clin Chem 2000;46:1039-40.
15. Chan KCA, Yeung SW, Lui WB, Rainer TH, LoYMD. Effects of preanalytical factors on the molecular size of cell-free DNA in blood. Clin Chem 2005; 51:781-4.
16. Leung SF, Zee B, Ma BB, et al. Plasma Epstein-Barr viral deoxyribonucleic acid quantitation complements tumor-node-metastasis staging prognostication in nasopharyngeal carcinoma. J Clin Oncol 2006;24: 5414-8.
17. Chan KCA, Zhang J, Chan ATC, et al. Molecular characterization of circulating EBV DNA in the plasma of nasopharyngeal carcinoma and lymphoma patients. Cancer Res 2003;63:2028-32.
18. Chan KCA, Zhang J, Hui AB, et al. Size distributions of maternal and fetal DNA in maternal plasma. Clin Chem 2004;50:88-92.
19. Tryggvason K, Wartiovaara J. Molecular basis of glomerular permselectivity. Curr Opin Nephrol Hypertens 2001;10:543-9.
20. Chan ATC, Lo YMD, Zee B, et al. Plasma Epstein-Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma. J Natl Cancer Inst 2002;94:1614-9.
21. Lo YMD, Chan ATC, Chan LYS, et al. Molecular prognostication of nasopharyngeal carcinoma by quantitative analysis of circulating Epstein-Barr virus DNA. Cancer Res 2000;60:6878-81.